# Efficacy and Safety Study of EGCG/Tocotrienol in 18 Patients With Splicing-mutation-mediated Cystic Fibrosis (CF)

> **NCT00889434** · NA · COMPLETED · sponsor: **Hadassah Medical Organization** · enrollment: 7 (actual)

## Conditions studied

- Cystic Fibrosis

## Interventions

- **DIETARY_SUPPLEMENT:** ECGC
- **DIETARY_SUPPLEMENT:** Tocotrienol
- **DIETARY_SUPPLEMENT:** EGCG + Tocotrienol

## Key facts

- **NCT ID:** NCT00889434
- **Lead sponsor:** Hadassah Medical Organization
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11-01
- **Primary completion:** 2015-04-16
- **Final completion:** 2015-04-16
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2017-11-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00889434

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00889434, "Efficacy and Safety Study of EGCG/Tocotrienol in 18 Patients With Splicing-mutation-mediated Cystic Fibrosis (CF)". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT00889434. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*